Literature DB >> 8633691

Amphetamine use: return of an old scourge in a consultation psychiatry setting.

H T Baberg1, R A Nelesen, J E Dimsdale.   

Abstract

OBJECTIVE: Recreational use of amphetamine and its analogues has increased considerably during the last decade. The aim of this study was to determine possible demographic characteristics of amphetamine users and nonusers who were seen in psychiatric consultations on inpatient medical and surgery wards.
METHOD: The authors examined data from 2,983 patients admitted to the University of California, San Diego, Medical Center and seen by consultation-liaison psychiatrists from January 1989 to June 1995. Amphetamine use was identified by the results of toxicological screening or patients' self-reports.
RESULTS: Throughout the interval covered by the analysis, 8.7% of the patients with consultations were current amphetamine users. The percentage of users decreased from 9.1% in 1989 to 4.5% in 1992 but increased after that to reach 15.6% in the first half of 1995. The users were generally younger than the nonusers; they were typically male, white, single, uninsured, and unemployed. In comparison with nonusers, the users were more likely to have a past psychiatric history (outpatient treatment or inpatient admission) and a family history of psychiatric disorder. The users were more often admitted because of suicide attempts, had a higher probability of being HIV-positive, and were overrepresented in the psychiatric consultations requested by the departments of infectious diseases, obstetrics/gynecology, and trauma surgery.
CONCLUSIONS: The high prevalence of amphetamine-using patients referred for psychiatric consultation is striking. Although young white men were especially likely to be users, there were users in all age groups, in nearly all hospital wards, and with a variety of psychiatric symptoms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633691     DOI: 10.1176/ajp.153.6.789

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  10 in total

1.  Psychostimulant dependence in a community sample.

Authors:  Li-Tzy Wu; William E Schlenger
Journal:  Subst Use Misuse       Date:  2003-01       Impact factor: 2.164

2.  Use of potentially abusive psychotropic substances in psychiatric inpatients.

Authors:  J Modestin; C Nussbaumer; K Angst; P Scheidegger; D Hell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

3.  Visual memory in methamphetamine-dependent individuals: deficient strategic control of encoding and retrieval.

Authors:  Erin E Morgan; Steven P Woods; Amelia J Poquette; Ofilio Vigil; Robert K Heaton; Igor Grant
Journal:  Aust N Z J Psychiatry       Date:  2012-02       Impact factor: 5.744

Review 4.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

5.  An ethnographic exploration of self-reported violence among rural methamphetamine users.

Authors:  Rocky L Sexton; Robert G Carlson; Carl G Leukefeld; Brenda M Booth
Journal:  J Ethn Subst Abuse       Date:  2009       Impact factor: 1.507

6.  Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV.

Authors:  Ni Sun-Suslow; Rowan Saloner; Vanessa Serrano; Anya Umlauf; Erin E Morgan; Ronald J Ellis; Scott Letendre; Igor Grant; Robert K Heaton
Journal:  AIDS Behav       Date:  2020-11

7.  Methamphetamine abuse and emergency department utilization.

Authors:  J R Richards; S W Bretz; E B Johnson; S D Turnipseed; B T Brofeldt; R W Derlet
Journal:  West J Med       Date:  1999-04

8.  Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.

Authors:  Jennifer E Iudicello; Steven P Woods; Ofilio Vigil; J Cobb Scott; Mariana Cherner; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2010-03-02       Impact factor: 2.475

9.  Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users.

Authors:  Jordan E Cattie; Steven Paul Woods; Jennifer E Iudicello; Carolina Posada; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

10.  Open-label pilot study of modafinil for methamphetamine dependence.

Authors:  Janette McGaugh; Michael J Mancino; Zachary Feldman; Mohit P Chopra; W Brooks Gentry; Christopher Cargile; Alison Oliveto
Journal:  J Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.